Stopping Cancer Early – The Best Possible Investment


Canary PASS

July 30, 2018

Canary Foundation has helped launch a new website devoted to PASS (Prostate Active Surveillance Study), our research study for men who have chosen active surveillance as a management plan for their prostate cancer.

The website includes the PASS Risk Calculator, a new tool designed to estimate the likelihood that a participant’s prostate cancer will become more aggressive and require treatment.